[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337121-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337121-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","paraneoplastic-syndromes-of-the-nervous-system-in-patients-suffering-from-sclc-a-review-of-the-recent-literature","Paraneoplastic Syndromes of the Nervous System in Patients Suffering from SCLC - A Review of the Recent Literature","","Paraneoplastic Neurological Syndromes (PNS) represent a heterogeneous set of neurological manifestations linked to underlying cancers, with Small Cell Lung Cancer (SCLC) showing a strong association. This narrative review surveys PubMed and related literature to describe how PNS appear in SCLC, summarize key published findings, and explain diagnostic criteria. It emphasizes antibody-mediated mechanisms via onconeural antibodies and reviews therapeutic options such as immunosuppressants, IV immunoglobulins, plasma exchange, rituximab, cyclophosphamide, azathioprine, and tocilizumab. The review highlights generally poor outcomes, relapse, and the need for multidisciplinary care to improve prognosis and quality of life.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/paraneoplastic-syndromes-of-the-nervous-system-in-patients-suffering-from-sclc-a-review-of-the-recent-literature/337121/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/paraneoplastic-syndromes-of-the-nervous-system-in-patients-suffering-from-sclc-a-review-of-the-recent-literature/337121.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are paraneoplastic neurological syndromes and why are they linked to SCLC?","Question",{"text":63,"@type":64},"PNS are neurological manifestations associated with underlying cancers. The review states that SCLC is strongly related to PNS, with immune responses contributing to neurological dysfunction.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are PNS diagnosed according to the review?",{"text":68,"@type":64},"Diagnosis follows specific criteria. The review attributes causation to tumor-directed onconeural antibodies and their effects on the nervous system.",{"name":70,"@type":61,"acceptedAnswer":71},"What treatment approaches are considered for PNS in SCLC patients?",{"text":72,"@type":64},"The review discusses immunosuppressants, intravenous immunoglobulins, plasma exchange, rituximab, cyclophosphamide, azathioprine, and tocilizumab. It also notes the importance of timing for initiating treatment and multidisciplinary management.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337121,1790536057,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Clinical Medicine   Narrative Review  \nActa Medica Academica 2024;53(2):176-182 DOI: 10.5644/ama2006-124 .452  \nParaneoplastic Syndromes ofthe Nervous System in Patients Suffering from SCLC. A Review of the Recent Literature  \nEmmanouel Georgiannakis, Theoni Zougou, Evaggelos Mavrommatis Medical School, National and Kapodistrian University of Athens, Athens, Greece Correspondence: [evagmavrommatis@protonmail.com](evagmavrommatis@protonmail.com); Tel.: + 30 697 6778252  \nReceived: 4 May 2024; Accepted: 23 August 2024  \nAbstract  \nBackground. Paraneoplastic Neurological Syndromes (PNS) constitute a heterogeneous cluster of disease manifestations related to various cancers. Small Cell Lung Cancer (SCLC) is strongly related to PNS. This narrative review conducted a survey in the available PubMed literature to highlight the appearance of PNSs in SCLC cases and discuss published research highlights on the subject so that general practitioners can be acquainted with the medical phenomenon present in SCLC patients. Method. A narrative review of the medical literature was conducted as documentary informative research in the PubMed medical database, combined with a survey of the online e-library Google Books. The key words used were: “Paraneoplastic Neurological Syndromes” and “Small Cell Lung Cancer”. Results. Paraneoplastic syndromes are related to the presence of a malignancy and are not secondary to treatment. Paradoxally, both a malignancy and its therapeutic approach may cause a series of PNSs. Paraneoplastic cerebellar degeneration, motor neuron disorders, peripheral neuropathies, hyponatremia, and syndromes such asmyasthenic Lambert-Eaton, ectopic Cushing’s, Stiffman, and Opsoclonus-myoclonus syndrome may also appear in SCLC cases. Diagnosis follows specific criteria, and they are caused by tumor-directed antibodies known as onconeural antibodies. Immunosuppressants, intravenous immunoglobulins, plasma exchange, rituximab, cyclophosphamide, azathioprine, and tocilizumab could be considered as treatment agents. Conclusions. Most patients demonstrate poor PNS treatment results with common relapse. The time for beginning treatment of PNS is discussed. A multidisciplinary team is needed for potentially earlier diagnosis and PNS improvement, better prognosis, and increased overall survival and quality of life.  \nKeyWords: Immune Response 􀂃 Neuro-Oncology 􀂃 Onconeural Antibodies 􀂃 Multidisciplinary Team.  \nIntroduction  \nParaneoplastic syndromes of the nervous system represent a group of uncommon disorders that develop in some people who have cancer. It is believed that they are a neurological response, which has been demonstrated in studies of lung malignancies in recent years (1) . The pathophysiology of paraneoplastic neurological syndromes involves a complex interplay between the immune and nervous systems. While the exact mechanisms vary depending on the specific syndrome, common features have been observed, such as the immune response, which is believed to arise from the antigens expressed by both the tumor and the nervous system. These antigens are often referred to  \nas onconeural antigens. In most cases, the immune system recognizes and eliminates cells expressing these antigens, but the acute and high volume production of tumor-directed antibodies, known as onconeural antibodies, dysregulates homeostasis. This cross-reaction results in the mistaken targeting of normal neural tissues, leading to neuronal dysfunction or damage. The cytotoxicity found in cells such as cytotoxic T cells, can infiltrate neural tissue in response to the presence of onconeural antigens.  \nThe presence of such immune reactions may alter or disrupt normal neuronal function through various mechanisms, including blocking synaptic transmission, receptor function, induced  \n176   Copyright © 2024 Georgiannakis et al. This article is available under a Creative Commons License  \n(Attribution 4.0 International, as described at [https://creativecommons.org/l","cbCaicbW5a65rjWX","https://ap.wps.com/l/cbCaicbW5a65rjWX","pdf",390280,"English","# Abstract\n# Introduction\n## Immune mechanisms in PNS\n## SCLC epidemiology and neurologic complication rates\n# Key topics and clinical manifestations (as summarized in the review)","[{\"question\":\"What are paraneoplastic neurological syndromes and why are they linked to SCLC?\",\"answer\":\"PNS are neurological manifestations associated with underlying cancers. The review states that SCLC is strongly related to PNS, with immune responses contributing to neurological dysfunction.\"},{\"question\":\"How are PNS diagnosed according to the review?\",\"answer\":\"Diagnosis follows specific criteria. The review attributes causation to tumor-directed onconeural antibodies and their effects on the nervous system.\"},{\"question\":\"What treatment approaches are considered for PNS in SCLC patients?\",\"answer\":\"The review discusses immunosuppressants, intravenous immunoglobulins, plasma exchange, rituximab, cyclophosphamide, azathioprine, and tocilizumab. It also notes the importance of timing for initiating treatment and multidisciplinary management.\"}]","Paraneoplastic Syndromes of the Nervous System in Patients Suffering from SCLC - A Review of the Recent Literature | PDF",1790017772,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33f68c90810573e1da1b80077d2963b8.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0ad89801b515ad01b7fdd9213db0e23.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/581f2fba74b34258f851547b5d586724.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8c54fb366401ce8fc20cf532df5d3b0.webp",980,1306]